Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Debt / NOTE 4.000%11/1
-
Number of holders
-
9
-
Total 13F principal, excl. options
-
17.8M
-
Principal change
-
-15.4M
-
Total reported value, excl. options
-
$37.2M
-
Value change
-
+$4.76M
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$0.98
Significant Holders of ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2025
12 filings reported holding 29664WAB1 - ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 as of Q1 2025.
ESPERION THERAPEUTICS INC NE - NOTE 4.000%11/1 has 9 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $17.8M of principal
.
Largest 10 bondholders include Pentwater Capital Management LP ($10.9M of principal), Jefferies Financial Group Inc. ($2.7M of principal), DeepCurrents Investment Group LLC ($2.4M of principal), OAKTREE CAPITAL MANAGEMENT LP ($774K of principal), Russell Investments Group, Ltd. ($585K of principal), ZAZOVE ASSOCIATES LLC ($375K of principal), DCF Advisers, LLC ($100K of principal), Context Capital Management, LLC ($12.4K of principal), Chicago Capital Management, LLC ($7.5K of principal), and AMERIPRISE FINANCIAL INC ($0 of principal).
This table shows the top 9 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.